
Dynamic Contrast Enhanced Ultrasonography (DCE-US)
Early functional evaluation of new treatments in oncology is of major importance. Overall survival rate is the best criterion for assessing treatment, but unfortunately it calls for lengthy follow-up whereas treatment efficacy must be ascertained as soon as possible. The morphological criteria normally used (WHO or RECIST) do not lend themselves easily to new therapies which often induce lesion…